Review Article
Treating Chronic Pain with SSRIs: What Do We Know?
Table 3
Assessment of the risk of bias of the included studies.
| | Reference | Random sequence generation | Allocation concealment | Blinding of participants and personnel | Blinding of primary outcome assessment | Incomplete outcome data | Selective reporting |
| | [38] | − | ? | − | − | − | − | | [32] | − | ? | − | − | − | − | | [41] | ? | − | − | − | + | − | | [16] | − | − | − | − | − | − | | [34] | ? | − | − | − | − | − | | [35] | ? | + | + | + | − | − | | [43] | ? | − | − | − | − | − | | [17] | − | − | − | − | − | − | | [49] | ? | − | − | − | − | − | | [29] | ? | ? | − | − | + | − | | [51] | + | + | + | + | ? | − | | [22] | ? | ? | − | − | − | − | | [37] | + | ? | + | + | − | − | | [42] | − | − | − | − | + | − | | [54] | + | + | + | + | − | − | | [21] | ? | ? | − | − | ? | − | | [26] | − | + | + | ? | − | − | | [50] | ? | − | − | ? | ? | − | | [28] | ? | ? | + | + | ? | − | | [44] | ? | ? | − | − | ? | − | | [56] | + | − | − | − | ? | − | | [45] | ? | − | − | − | ? | − | | [61] | ? | ? | + | + | − | − | | [62] | − | − | − | − | − | − | | [36] | ? | − | − | − | ? | − | | [63] | − | − | − | − | − | − | | [52] | − | − | + | + | − | − | | [19] | − | − | − | − | − | − | | [46] | ? | ? | + | − | ? | − | | [58] | + | + | + | + | − | − | | [53] | ? | − | − | − | ? | − | | [33] | ? | − | − | − | + | − | | [57] | − | − | − | − | ? | − | | [27] | − | − | − | − | ? | − | | [18] | ? | − | − | − | − | − | | [47] | + | + | + | + | − | − |
|
|
−: low risk, +: high risk, and ?: unknown risk.
|
